Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed, 2 Injured in Crash at Avenue 432 and Road 120


Driver Runs Stop Sign in Fatal Orosi Accident

accidentnews1

Orosi, CA (March 2, 2020) – A man was killed and two others were injured in a crash in Orosi. The fatal accident occurred on the morning of March 2 at Avenue 432 and Road 120.

The driver of a Chevy van failed to stop at a stop sign at the intersection. It crashed into a Mazda, which then hit a power pole.

A man inside the Mazda died at the accident scene. Two men in the van were airlifted to a local hospital.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Orosi

#93647


October 24, 2019

2 Injured in Crash on Highway 99 Near Dillard Road

3 Vehicles Involved in Wilton Accident Wilton, CA (October 22, 2019) – Two pe...


May 11, 2020

Dairy Worker Killed During Robbery on South Ingomar Avenue

Hector DeLaCruz Arrested in Fatal Gustine Shooting...


April 24, 2020

1 Killed in Crash at Olive and Cedar Avenues

Police Chase Leads to Fatal Fresno Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.